Pandemic's hidden toll: surgery patients share their stories
NCT ID NCT05736822
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explored how changes in healthcare during the COVID-19 pandemic (2020-2021) impacted the quality of life and experiences of over 5,000 Dutch patients who had surgery or another medical procedure. Researchers first held focus groups to understand key themes, then created a questionnaire to measure patient experiences. The goal was to learn from patients to improve care during future health emergencies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
5,277 people
The number who actually took part.
- Started
-
Nov 2023
- Finished
-
Apr 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
(former) surgical, orthopedic, cardiological patients
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * undergoing surgery or intervention in the Netherlands in 2020 or 2021 Exclusion Criteria: * participation language restricted to Dutch
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UMCG
Groningen, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A phase 2, randomized, Observer-Blind, dose ranging study to evaluate the safety, reactogenicity, and immunogenicity of mRNA-1283 in participants ≥6 months to <12 years of age
- Can an old malaria drug help fight severe COVID-19?
- A single swab, two diseases: rapid test takes on TB and COVID-19
- A central vault for COVID-19 samples could speed up research
- Can a new vaccine bolster defenses against COVID-19?
- Can new vaccines outsmart COVID-19 variants?